Context Therapeutics regains Nasdaq minimum bid price compliance

Context Therapeutics Inc.

Received Nasdaq letter on Oct 17, 2025 confirming compliance regained after 10 consecutive business days with closing bid price at or above $1.00.
Company had been noncompliant since Feb 27, 2025; granted extension to Feb 23, 2026.
Nasdaq considers the matter closed; delisting risk removed.
Stock ticker CNTX trades on Nasdaq under Minimum Bid Price Rule 5550(a)(2).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.